Amgen
A Specialist Manufacturing: NPI, Process Owner at Amgen supports the biologics drug substance manufacturing plant in North Carolina, focusing on new product introductions and downstream process ownership. The role connects manufacturing and process development to enable successful technology transfer and support scalable drug substance production in service of Amgen’s patient-focused mission.
Headquarters
Thousand Oaks, California, United States
Company Size
10001+ employees
Founded
1980
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Amgen.
Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: Wall Street's Latest Biopharma Calls Explained
1 day ago
Associate Director, Drug Substance Manufacturing – Downstream Process
Vera Therapeutics, Inc.
Senior Process Engineer - Manufacturing Sciences & Technology, Downstream
Catalent
Associate Director, Technical Operations, Biologics Drug Substance Manufacturing
Travere Therapeutics
Associate Principal Scientist/Associate Director, Engineering- Biologics Drug Substance Commercialization
MSD
Sr Director Drug Substance Facility Lead (m/f/d)
MSD
Principal Research Scientist II
AbbVie